SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 6
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
6
|
presentations:
1 to
50 of
287
|
SYPHILIS CAUSES STILLBIRTH: PENICILLIN IS PREVENTION
(ABSTRACT
54)
Melanie Taylor
World Health Organization, Geneva, Switzerland
CHLAMYDIA AND GONORRHOEA IN PREGNANCY: SILENCE OF THE GERMS
(ABSTRACT
55)
Nicola Low
University of Bern, Bern, Switzerland
MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B: CAN IT BE ELIMINATED?
(ABSTRACT
56)
Yusuke Shimakawa
Institut Pasteur, Paris, France
BEYOND THE STIGMA: A SORELY NEEDED PERSPECTIVE ON HSV
(ABSTRACT
57)
Anna Wald
University of Washington, Seattle, WA, USA
IN VIVO MODELS FOR THE EVALUATION OF NOVEL HIV CURE INTERVENTIONS
(ABSTRACT
50)
J. Victor Garcia-Martinez
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
LRA 2.0: IMMUNE-BASED LATENCY REVERSAL
(ABSTRACT
51)
Ann Chahroudi
Emory University, Atlanta, GA, USA
T-CELL AND HEMATOPOIETIC STEM CELL GENE THERAPIES FOR HIV CURE
(ABSTRACT
52)
Christopher Peterson
Fred Hutchinson Cancer Research Center, Seattle, USA
TOWARD DURABLE CONTROL OF HIV-1 WITH ECD4-IG
(ABSTRACT
53)
Michael Farzan
The Scripps Research Institute, Jupiter, FL, USA
REFLECTIONS ON THE UK EPIDEMIC
(ABSTRACT
58)
Valerie Delpech
Public Health England, London, United Kingdom
30-PLUS YEARS OF HIV IN RAKAI: THE EPIDEMIC RECEDES
(ABSTRACT
59)
Joseph Kagaayi
Makerere University school of Public Health, and Rakai Health Science Program, Kampala, Uganda
BATTLING HIV IN THE US RURAL SOUTH
(ABSTRACT
60)
Leandro Antonio Mena
University of Mississippi Medical Center, Jackson, MS, USA
HOW DO WE STOP THE BAND FROM PLAYING ON IN THE US?
(ABSTRACT
61)
Carlos Del Rio
Emory University, Atlanta, GA, USA
GLOBAL EPIDEMIOLOGY AND PREVENTION OF COVID-19
John T Brooks
Centers for Disease Control and Prevention, Atlanta, GA, USA
VIROLOGY OF CORONAVIRUSES
Ralph S Baric
University of North Carolina Chapel Hill, Chapel Hill, NC, USA
OUTBREAK OF COVID-19 IN CHINA AND THE COUNTRY'S RESPONSES
Zunyou Wu
THE RESEARCH RESPONSE TO COVID-19: A VIEW FROM NIAID
Anthony S Fauci
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
GLOBAL ELIMINATION OF HEPATITIS B VIRUS
(ABSTRACT
103)
Gilles Wandeler
Bern University Hospital, Bern, Switzerland
ADAPTING THE IMMUNE RESPONSE TO CURE HEPATITIS B
(ABSTRACT
104)
Barbara Rehermann
National Institutes of Health, Bethesda, MD, USA
HEPATITIS B VIRUS: NEW AGENTS
(ABSTRACT
105)
Raymond T Chung
Massachusetts General Hospital, Boston, MA, USA
THE MATHEMATICS OF HEPATITIS B CURE
(ABSTRACT
106)
Alan S. Perelson
Los Alamos National Laboratory, Los Alamos, NM, USA
DRUG-DRUG INTERACTIONS: THE UPS AND DOWNS OF ANTIRETROVIRALS PLUS CONTRACEPTIVES
(ABSTRACT
107)
Kimberly K. Scarsi
University of Nebraska Medical Center, Omaha, NE, USA
CONTRACEPTIVE IMPLANT ROLLOUT IN SOUTH AFRICA
(ABSTRACT
108)
Gregory Petro
University of Cape Town, Observatory, Western Cape, South Africa
CONTRACEPTION AND HIV RISK: A CONUNDRUM NO MORE
(ABSTRACT
109)
Renee Heffron
University of Washington, Seattle, WA, USA
THE STATE OF SRHR & HIV SERVICES FOR CISGENDER WOMEN: A COMMUNITY PERSPECTIVE
(ABSTRACT
110)
Wame Jallow
International Treatment Preparedness Coalition, Gaborone, Botswana
STING IN THE TAIL: HOW DNA TRIGGERS IMMUNE RESPONSES TO VIRAL INFECTIONS
(ABSTRACT
95)
Zhijian (James) Chen
UT Southwestern Medical Center, Dallas, TX, USA
TRIM5 RECOGNITION AND RESTRICTION OF HIV-1 AND RETROVIRUSES
(ABSTRACT
96)
Owen Pornillos
University of Virginia, Charlottesville, VA, USA
HIV-1 AVOIDS BEING ZAPPED
(ABSTRACT
97)
Janet L Smith
University of Michigan, Ann Arbor, MI, USA
SERINC STRUCTURE AND RESTRICTION OF HIV-1 INFECTIVITY
(ABSTRACT
98)
Valerie Pye
The Francis Crick Institute, London, UK, United Kingdom
NEUROHIV IN THE GLOBAL CONTEXT: ADVANCING THE CONTINUUM OF CARE AND ACHIEVING EQUITY
(ABSTRACT
99)
Kiran T Thakur
Columbia University Irving Medical Center, New York, NY, USA
HIV-ASSOCIATED NEUROCOGNITIVE DISORDERS AND AGING IN THE GLOBAL SETTING
(ABSTRACT
100)
John Joska
University of Cape Town, Cape Town, South Africa
HIV AND MENTAL HEALTH: THE IMPACT OF THE COMORBIDITY IN RESOURCE-CONSTRAINED SETTINGS
(ABSTRACT
101)
Bibilola D Oladeji
University of Ibadan, Ibadan, Nigeria
CEREBROVASCULAR COMPLICATIONS AND NEUROHIV IN THE GLOBAL SETTING
(ABSTRACT
102)
Felicia C Chow
University of California San Francisco, San Francisco, CA, USA
INTRODUCTION OF HVTN 702 STUDY
Lawrence Corey
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
PRESENTATION OF HVTN 702 STUDY DATA
Glenda Elisabeth Gray
University of the Witwatersrand, Soweto, South Africa
NOVEL ANTIRETROVIRAL AGENTS: TRANSFORMING THE CARE OF PEOPLE WITH HIV
(ABSTRACT
157)
Rajesh T Gandhi
Massachusetts General Hospital, Boston, MA, USA
PEDIATRIC AND ADOLESCENT ART: A ROAD LESS TRAVELLED
(ABSTRACT
158)
Carolyn Bolton Moore
University of Alabama at Birmingham, Lusaka, Zambia
METABOLIC COMPLICATIONS OF HIV AND ITS THERAPIES
(ABSTRACT
159)
Jordan E Lake
University of Texas Health Science Center Houston, Houston, TX, USA
GETTING IT RIGHT: PRACTICAL APPROACHES TO ADHERENCE WITH MODERN ARVS
(ABSTRACT
160)
Jose R Castillo-Mancilla
University of Colorado Denver, Aurora, CO, USA
USING SYSTEMS BIOLOGY TO UNDERSTAND THE MECHANISMS OF VACCINE EFFICACY
(ABSTRACT
153)
Bali Pulendran
Stanford University, Stanford, USA
DECODING THE TRANSCRIPTIONAL INFLAMMATORY CASCADES THAT MAINTAIN HIV RESERVOIR
(ABSTRACT
154)
Susan Pereira Ribeiro
Case Western Reserve University, Cleveland, OH, USA
DISSECTING THE DRIVERS OF CHRONIC INFLAMMATION
(ABSTRACT
155)
Krystelle Nganou
University Hospital Erlangen, Erlangen, Germany
DEFINING TREATABLE PATHWAYS IN INFLAMMAGING: IS IT NICE TO FOOL WITH MOTHER NATURE?
(ABSTRACT
156)
Michael M Lederman
Case Western Reserve University, Cleveland, OH, USA
GLOBAL EPIDEMIOLOGY OF HEPATITIS C
(ABSTRACT
161)
Yvan J-F Hutin
World Health Organization, Cairo, Egypt
MODELING AND EXAMPLES OF HCV ELIMINATION: POSSIBILITIES, ACHIEVEMENTS, AND NEXT STEPS
(ABSTRACT
162)
Natasha Martin
University of California San Diego, San Diego, CA, USA
VERTICAL HEPATITIS C TRANSMISSION: DÉJÀ VU ALL OVER AGAIN?
(ABSTRACT
163)
Ali Judd
University College London, London, United Kingdom
HEPATITIS C TREATMENT ON A SHOESTRING
(ABSTRACT
164)
Isabelle Andrieux-Meyer
Drugs for Neglected Diseases Initiative, Geneva, Switzerland
CHASING THE DRAGON: OPIATES AND HIV
(ABSTRACT
63)
Ricky N Bluthenthal
University of Southern California, Los Angeles, CA, USA
CHEMSEX AND IMPLICATIONS FOR HIV TRANSMISSION AND MANAGEMENT
(ABSTRACT
64)
Mark Rohan Pakianathan
St George's University Hospital, London, United Kingdom
HIDDEN IN PLAIN SIGHT: THE ALCOHOL EPIDEMIC
(ABSTRACT
65)
Leickness Chisamu Simbayi
Human Sciences Research Council, Cape Town, South Africa
|
<< first | < prev
page:
of 6
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
6
|
presentations:
1 to
50 of
287
|
